Hookipa Pharma Inc.
13F holders, Q4 2024 (December 31)1holders
0new positions
0sold out
$2.01avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Hookipa Pharma Inc. in their 13F filings, unchanged from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Knoll Capital Management, LLC ($1.0M).
- Company
- Hookipa Pharma Inc.
- CUSIP
- 43906K100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 53,113 shares sold, net −53,113 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Knoll Capital Management, LLC | 0.65% | Reduce -9.6% | 498,625 | $1.0M |
"% of holder's portfolio" is HOOKIPA PHARMA INC's weight in each manager's 13F, not the share of Hookipa Pharma Inc. the manager owns.